BX trades against a final fair-value range of $81.01-$178.71, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs. Fair value range: low $81.0, high $179, with mid-point at $126.
Trades close to fair value, so the margin of safety is limited either way.
Fair value
$126
Margin of safety
+1.7%
Confidence
78/100
Moat
9/10
Educational research only - not investment advice, an offer, or a trade instruction. Confirm current data and do your own due diligence before acting.
$123.77Price
Low $81.01
Mid $125.88
High $178.71
BX trades against a final fair-value range of $81.01-$178.71, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.
Reverse DCF for BX (BX) backs out the revenue or earnings growth rate the current share price implies, holding terminal value, margin, and discount-rate assumptions constant.
We compare the implied rate to our own forecast deceleration curve and to the historical five-year actual. When the implied rate exceeds the realistic ceiling, the price is pricing in optimism the business has not yet demonstrated.
Reverse DCF uses cost of equity (Ke), not WACC, to stay consistent with the EPS-based forward valuation models. Ke is derived from CAPM with adjusted beta; the strict and moderate variants are documented in the assumption ledger.
When the implied growth rate is below our forecast, the market is underpricing the business; when it is above, the market is overpricing. The reverse-DCF read is one of four lenses that feed the composite fair-value range and the rating band.
FAQ
BX — frequently asked questions
Based on our latest analysis, BX trades close to fair value. The current price is $124 versus a composite fair-value midpoint of $126 (range $81.0–$179), which implies roughly 1.7% upside to the midpoint.
Our composite fair-value range for BX is $81.0–$179, with a midpoint of $126. The range is triangulated across multiple valuation models (discounted earnings, forward earnings scenarios, peer multiples, and where applicable owner earnings or reverse DCF) and weighted by reliability for BX's archetype.
Our current rating for BX is Hold with a confidence score of 78/100. BX is rated Hold at $123.77 versus the reconciled fair value midpoint of $125.88, implying +1.70% upside/downside. Confidence is separately disclosed at 78/100. This is research for educational purposes, not personalized investment advice.
The top risks our latest report flags for BX are: Commercial Real Estate Meltdown; Prolonged High Rate Regime; Retail Channel Retreat. The single biggest risk is Hold for long-term secular private market tailwinds.
Our current rating for BX is Hold, issued with a confidence score of 78/100 and a moat score of 9/10. The rating reflects the composite fair-value range ($81.0–$179) versus the current price of $124.
BX is classified as a financial stock. Archetype determines how every downstream parameter — discount rate, terminal growth, deceleration curve, terminal multiple, scenario probability weights, scorecard weights, and which valuation models are prioritized — is calibrated for BX.